CoChat

ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors

Open access

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Abstract

The proliferative action of ERalpha largely accounts for the carcinogenic activity of estrogens. By contrast, recent data show that ERbeta displays tumor-suppressor properties, thus supporting the interest to identify compounds that could increase its activity. Here, we show that histone deacetylase inhibitors (HDI) upregulated ERbeta protein levels, whereas it decreased ERalpha expression. Part of this regulation took place at the mRNA level through a mechanism independent of de novo protein synthesis. In addition, we found that, in various cancer cells, the treatment with different HDI enhanced the ligand-dependent activity of ERbeta more strongly than that of ERalpha. On the other hand, in MDA-MB231 and HeLa cells, the expression of ERs modified the transcriptional response to HDI. The use of deletion mutants of both receptors demonstrated that AF1 domain of the receptors was required. Finally, we show that ERbeta expression led to a dramatic increased in the antiproliferative activity of HDI, which correlated with a modification of the transcription of genes involved in cell cycle control by HDI. Altogether, these data demonstrate that the interference of ERbeta and HDAC on the control of transcription and cell proliferation constitute a promising approach for cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209102

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. McKenna NJ, O’Malley BW . (2002). Endocrinology 143: 2461–2465. · doi:10.1210/endo.143.7.8892 · Paper page

Cited by

See all 77

Metadata

Authors
Duong, V, Licznar, A., Margueron, R., Boulle, N., Busson, M., Lacroix, M., Katzenellenbogen, B. S., Cavaillès, V, & Lazennec, G.
Affiliations
  • Inserm (FR)
  • Hôpital Arnaud de Villeneuve (FR)
  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
  • University of Illinois Urbana-Champaign (US)
Corresponding author
  • Cavaillès, V
  • Lazennec, G
Venue
Oncogene
Published
2005-09-12
Volume
25
Issue
12
Pages
1799-1806
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1590835357
Cited by
75
References
37
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 9
FWCI
2.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Ligue Contre le Cancer
  • National Institutes of Health
  • National Cancer Institute (CA 18119, R01CA018119)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
estrogen receptor alpha, estrogen receptor beta, histone deacetylase inhibitors, transcriptional regulation, mRNA stability, cell proliferation, cell cycle regulation, cancer therapy, MDA-MB-231 cells, HeLa cells
MeSH terms
Enzyme Inhibitors, HeLa Cells, Histone Deacetylases, Humans, RNA, Messenger, Transcription, Genetic, Blotting, Western, Polymerase Chain Reaction, Apoptosis, Estrogen Receptor alpha, Estrogen Receptor beta, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors. https://app.cochat.ai/papers/10.1038/sj.onc.1209102
The paper
Duong, V, Licznar, A., Margueron, R., Boulle, N., Busson, M., Lacroix, M., Katzenellenbogen, B. S., Cavaillès, V, & Lazennec, G. (2006). ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors. Oncogene. https://doi.org/10.1038/sj.onc.1209102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.